11. P1‐047: REGIONAL COGNITIVE DIFFERENCES IN REFERRALS TO THE ELENBECESTAT MISSIONAD PHASE 3 PROGRAM IN EARLY ALZHEIMER'S DISEASE. (1st July 2019) Authors: Doherty, Thomas; Murphy, Jennifer; Marsh, Julie; Koschalka, Luke; Martinez, Mairelys; Gee, Michelle; Albala, Bruce Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 4 Page Start: P250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. P3‐459: EQUIVALENCE OF DIFFERENT LANGUAGE VERSIONS OF THE INTERNATIONAL SHOPPING LIST TEST IN THE PHASE 3 MISSION AD STUDIES. (1st July 2019) Authors: Schembri, Adrian; Maruff, Paul; Gee, Michelle; Albala, Bruce Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 22 Page Start: P1140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. P4‐163: A single dose of the beta‐secretase inhibitor, e2609, decreases CSF bace1 enzymatic activity in cynomolgus monkeys. (1st July 2015) Authors: Matijevic, Mark; Watanabe, Hideki; Sato, Yoshiaki; Bernier, Francois; McGrath, Shannon; Burns, Lynne; Yamamoto, Noboru; Ogo, Makoto; Dezso, Zoltan; Chow, Jesse; Oda, Yoshiya; Kaplow, June; Albala, Bruce Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7:Part 18 Page Start: P841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. P4‐389: ELENBECESTAT, E2609, A BACE INHIBITOR: RESULTS FROM A PHASE‐2 STUDY IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT AND MILD‐TO‐MODERATE DEMENTIA DUE TO ALZHEIMER'S DISEASE. (1st July 2006) Authors: Lynch, Shau Yu; Kaplow, June; Zhao, Jim; Dhadda, Shobha; Luthman, Johan; Albala, Bruce Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7(2018)Part 31 Page Start: P1623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. P4–411: Clinical study of E2609, a novel BACE1 inhibitor, demonstrates target engagement and inhibition of BACE1 activity in CSF. (1st July 2013) Authors: Bernier, Francois; Sato, Yoshiaki; Matijevic, Mark; Desmond, Howard; McGrath, Shannon; Burns, Lynne; Kaplow, June M.; Albala, Bruce Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 22 Page Start: P886 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project. Issue 2 (1st October 2016) Authors: Ritchie, Karen; Ropacki, Michael; Albala, Bruce; Harrison, John; Kaye, Jeffrey; Kramer, Joel; Randolph, Christopher; Ritchie, Craig W. Journal: Alzheimer's & dementia Issue: Volume 13:Issue 2(2017) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. RTID-03. A PHASE I CLINICAL TRIAL TO EVALUATE MTD OF PERAMPANEL AND MEMANTINE IN COMBINATION WITH STANDARD CHEMORADIOTHERAPY FOR THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GBM –A STUDY DESIGN. (9th November 2020) Authors: Kong, Xiao-Tang; Albala, Bruce; Du, Senxi; Hrachova, Maya; Bota, Daniela Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. RTID-04. A RANDOMIZED PHASE II TRIAL TO COMPARE THE EFFICACY OF STANDARD VERSUS COMBINATION THERAPY (PERAMPANEL, MEMANTINE PLUS STANDARD) IN THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GBM-A STUDY DESIGN. (9th November 2020) Authors: Kong, Xiao-Tang; Albala, Bruce; Du, Senxi; Kong, Xiao-Tang; Bota, Daniela Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗